Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12070488 Methods of treating Kawasaki disease

Patent 12070488 was granted and assigned to Seattle Children's on August, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Seattle Children's
Seattle Children's
0
Date Filed
January 18, 2022
0
Date of Patent
August 27, 2024
0
Patent Applicant
Seattle Children's
Seattle Children's
0
Patent Application Number
17648242
0
Patent Citations
‌
US Patent 9453067 Stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc
0
‌
US Patent 9649383 Liquid formulations for TNFR:Fc fusion proteins
0
‌
US Patent 9662396 Stable aqueous formulations of etanercept
0
‌
US Patent 9700595 Liquid formulation of a fusion protein comprising TNFR and Fc region
0
‌
US Patent 9801942 Etanercept formulations stabilized with metal ions
0
‌
US Patent 11253569 Methods of treating Kawasaki Disease
0
‌
US Patent 8052645 System and method for an injection using a syringe needle
0
‌
US Patent 8177749 Cassette for a hidden injection needle
0
‌
US Patent 8920374 Drive control mechanisms and automatic injectors for injectable cartridges
0
‌
US Patent 9302002 Etanercept formulations stabilized with combinations of sugars and polyols
0
•••
Patent Inventor Names
Michael A. Portman
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12070488
0
Patent Primary Examiner
‌
Nora M Rooney
0

Find more entities like US Patent 12070488 Methods of treating Kawasaki disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.